Q3 2024 Arcadia Biosciences Inc Earnings Call Transcript
Key Points
- Arcadia Biosciences Inc (RKDA) reported an 18% year-over-year increase in total revenues for Q3 2024.
- Zola coconut water sales surged by 55% compared to the same period last year, contributing significantly to revenue growth.
- The company achieved the lowest level of cash usage in a quarter since going public, indicating improved financial management.
- Zola's retail store count increased by 68% year-over-year, marking the largest quarterly distribution gain in the company's history.
- Zola outpaced the coconut water category growth, with a 73% increase in the latest four-week period compared to the industry's 28% growth.
- Selling, general, and administrative expenses increased by $380,000 due to severance and transition-related fees.
- Sales of GLA oil continued to decline, with Q3 sales being about half of what they were in the same period last year.
- The company experienced a $150,000 write-down related to hemp and GoodWheat seed.
- There is uncertainty in forecasting due to the timing of initial shipments and the size of new distribution gains.
- The company did not provide forward-looking guidance, citing challenges in forecast accuracy due to recent distribution changes.
Good afternoon, and welcome to Arcadia Biosciences third-quarter 2024 financial results and business highlights conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to Mark Kawakami, Chief Financial Officer at Arcadia. Please go ahead.
Thank you, and good afternoon. Joining me on the call today is T.J. Schaefer, Arcadia's President and Chief Executive Officer. This call is beinga webcast, and you can refer to the company's press release at arcadiabio.com. Before we start, we would like to remind you that Arcadia Biosciences will be making forward-looking statements on this call based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied today.
You can review the company's safe harbor language in our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
